X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Aligned Pathway

    UK Grants Pharma Firms Early Access to Aligned Pathway

    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Aligned Pathway

    UK Grants Pharma Firms Early Access to Aligned Pathway

    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Clinical Trials

Enhancing Clinical Trial Success Rate Using eClinical Adaptive Trials Download

Yuvraj_pawp by Yuvraj_pawp
31st July 2014
in Clinical Trials

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Vsoft Infoware has released a white paper entitled ‘Enhancing Clinical Trial Success Rates Using eClinical Adaptive Trials’, which discusses improving the success rate of clinical trials using integrated eClincal adaptive solutions.

 

Vsoft Infoware, Inc, a Delaware Corp, was established in 1996, is a pioneer in integrated interactive eClinical solutions (patent pending) employing a SaaS (Software as a Service) model.

 

With operations in the US and India, Vsoft offers reliable and high-quality products and services to research based pharmaceutical and biotechnology companies worldwide. Through its ISO:9001 certified wholly owned subsidiary, Udison Infoware Pvt Ltd, Bangalore and its trained, experienced, and certified staff, Vsoft offers quality products and services to its global clients.

 

Clinfoware®, a fully integrated transactional system, and VDataWareTM, a data warehouse reporting tool, are flagship products of Vsoft. For more information please visit www.vsoftinfo.com or contact us on info@vsoftinfoware.com. Phone number: +1 908 864 5129.

Previous Post

Eisai and Arena Pharmaceuticals Announce BELVIQ(R) (lorcaserin HCl) CIV Nominated a Second Time for the Prix Galien Award in the Best Pharmaceutical Agent Category

Next Post

Meda agrees to acquire Rottapharm for €2.3bn

Related Posts

Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
Breast Cancer Therapy
Clinical Trials

US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

27th September 2025
Sensor Technology
Clinical Trials

Enhancing Clinical Research with Advanced Sensor Technology

11th September 2025
Agentic AI in Pharma Transforming RD to Commercialisation
Clinical Trials

Agentic AI in Pharma: Transforming R&D to Commercialisation

31st July 2025
The Future of Clinical
Clinical Trials

The Future of Clinical Trial Data in Decentralisation Models

30th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Next Post

Pfizer to acquire Baxter’s portfolio of marketed vaccines for $635m

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In